Evidence map›Paper›PMID 33672693›Full record

ArticleBrain sciences2021

Prepulse Inhibition in Cocaine Addiction and Dual Pathologies.

Isis Gil-Miravet, Alejandro Fuertes-Saiz, Ana Benito, Isabel Almodóvar, Enrique Ochoa, Gonzalo Haro

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Isis Gil-MiravetTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón, Spain.ORCID 0000-0002-1901-8804
Alejandro Fuertes-SaizTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón, Spain.ORCID 0000-0001-5410-8701
Ana BenitoTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón, Spain.
Isabel AlmodóvarTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón, Spain.ORCID 0000-0002-0580-664X
Enrique OchoaMolecular Biopathology Department, Consorcio Hospitalario Provincial de Castellón, 12002 Castellón, Spain.
Gonzalo HaroTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón, Spain.
Universidad Cardenal Herrera CEU · ESConsorcio Hospitalario Provincial de Castellón · ESUniversitat Jaume I · ES

Funding

CEU-Cardenal Herrera University Teaching+Research 2016 and Teaching+Research 2017Redes Temáticas de Investigación Cooperativa en Salud (RETICS), Red de Trastornos Adictivos, Complications of stimulant disorder, Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad Ref. RD16/0017/0024Research Foundation of the Hospital Provincial de Castellón CAF-20-026, CAF-20-027
6 · The paper itself

Abstract

Cocaine addiction is frequently associated with different psychiatric disorders, especially schizophrenia and antisocial personality disorder. A small number of studies have used prepulse inhibition (PPI) as a discriminating factor between these disorders. This work evaluated PPI and the phenotype of patients with cocaine-related disorder (CRD) who presented a dual diagnosis of schizophrenia or antisocial personality disorder. A total of 74 men aged 18-60 years were recruited for this research. The sample was divided into four groups: CRD (

Indexed as

antisocial personality disordercocaine-related disorderdual diagnosisprepulse inhibitionpsychopathyschizophrenia

Identifiers

PMID33672693
PMCPMC7924364
OpenAlexW3131257545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.